Tyrosine Kinase Inhibitor Sunitinib Targets the Vasculature of Clear Cell Renal Cell Carcinoma: A Histological and Immunocytochemical Study of Treatment Effect

被引：0
|
作者：
Huang, J. [1 ]
Thomas, A. [1 ]
Simmerman, K. [1 ]
Sercia, L. [1 ]
Magi-Galluzzi, C. [1 ]
Campbell, S. [1 ]
Rini, B. [1 ]
Zhou, M. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
873
引用
收藏
页码：197A / 197A
页数：1
相关论文
共 50 条
  • [1] Tyrosine Kinase Inhibitor Sunitinib Targets the Vasculature of Clear Cell Renal Cell Carcinoma: A Histological and Immunocytochemical Study of Treatment Effect
    Huang, J.
    Thomas, A.
    Simmerman, K.
    Sercia, L.
    Magi-Galluzzi, C.
    Campbell, S.
    Rini, B.
    Zhou, M.
    MODERN PATHOLOGY, 2010, 23 : 197A - 197A
  • [2] Tyrosine kinase inhibitor sunitinib targets the vasculature of clear cell renal cell carcinoma: a morphometrical study of treatment effect
    Chen, Lu
    Chen, Longwen
    Huang, Jie
    Xu, Danfeng
    Wang, Linhui
    Zhou, Ming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (03): : 3571 - 3578
  • [3] Sunitinib as a paradigm for tyrosine kinase inhibitor development for renal cell carcinoma
    Lee, Chung-Han
    Motzer, Robert J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (06) : 275 - 279
  • [4] Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor
    Hailiang Zhang
    Lin Bai
    Xin-Qiang Wu
    Xi Tian
    Jinwen Feng
    Xiaohui Wu
    Guo-Hai Shi
    Xiaoru Pei
    Jiacheng Lyu
    Guojian Yang
    Yang Liu
    Wenhao Xu
    Aihetaimujiang Anwaier
    Yu Zhu
    Da-Long Cao
    Fujiang Xu
    Yue Wang
    Hua-Lei Gan
    Meng-Hong Sun
    Jian-Yuan Zhao
    Yuanyuan Qu
    Dingwei Ye
    Chen Ding
    Nature Communications, 14
  • [5] Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor
    Zhang, Hailiang
    Bai, Lin
    Wu, Xin-Qiang
    Tian, Xi
    Feng, Jinwen
    Wu, Xiaohui
    Shi, Guo-Hai
    Pei, Xiaoru
    Lyu, Jiacheng
    Yang, Guojian
    Liu, Yang
    Xu, Wenhao
    Anwaier, Aihetaimujiang
    Zhu, Yu
    Cao, Da-Long
    Xu, Fujiang
    Wang, Yue
    Gan, Hua-Lei
    Sun, Meng-Hong
    Zhao, Jian-Yuan
    Qu, Yuanyuan
    Ye, Dingwei
    Ding, Chen
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [6] Molecular mechanisms of resistance to tyrosine kinase inhibitor in clear cell renal cell carcinoma
    Sekino, Yohei
    Teishima, Jun
    Liang, Gangning
    Hinata, Nobuyuki
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (12) : 1419 - 1428
  • [7] Histological heterogeneity contributes to sunitinib resistance in clear cell renal cell carcinoma
    Lichner, Zsuzsanna
    Saleeb, Rola
    Butz, Henriett
    Nofech-Mozes, Roy
    Riad, Sara
    Farag, Mina
    Kapus, Andras
    Yousef, George
    CANCER RESEARCH, 2017, 77
  • [8] Severe cardiomyopathy in a patient with renal cell carcinoma after treatment with the novel tyrosine kinase inhibitor sunitinib
    Chorianopoulos, E.
    Jager, D.
    Katus, H. A.
    Frey, N.
    CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (11) : 829 - 830
  • [9] Severe cardiomyopathy in a patient with renal cell carcinoma after treatment with the novel tyrosine kinase inhibitor sunitinib
    E. Chorianopoulos
    D. Jäger*
    H. A. Katus
    N. Frey
    Clinical Research in Cardiology, 2007, 96 : 829 - 830
  • [10] The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma
    Polena, Helena
    Creuzet, Julie
    Dufies, Maeva
    Sidibe, Adama
    Khalil-Mgharbel, Abir
    Salomon, Aude
    Deroux, Alban
    Quesada, Jean-Louis
    Roelants, Caroline
    Filhol, Odile
    Cochet, Claude
    Blanc, Ellen
    Ferlay-Segura, Celine
    Borchiellini, Delphine
    Ferrero, Jean-Marc
    Escudier, Bernard
    Negrier, Sylvie
    Pages, Gilles
    Vilgrain, Isabelle
    BRITISH JOURNAL OF CANCER, 2018, 118 (09) : 1179 - 1188
12345